Other Cancers

Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study.

BACKGROUND: Survival outcomes after transarterial chemoembolisation (TACE) vary in hepatocellular ca...

Detecting Distant Metastases in Prostate Cancer Using Whole-body MR Imaging Together with DWIBS (Diffusion-weighted Imaging with Background Body Signal Suppression).

Whole-body MRI (WB-MRI) has evolved over the past 2 decades as a noninvasive imaging technique for d...

The ATF5-GPER1 axis drives female protection in hepatocellular carcinoma through dual tumor-suppressive and immune-modulatory mechanisms.

Hepatocellular carcinoma (HCC) exhibits marked sexual dimorphism, with females demonstrating superio...

Explainable artificial intelligence for personalized prognosis in pancreatic cancer: A nationwide study from Taiwan.

Pancreatic cancer is highly aggressive with poor outcomes; current artificial intelligence (AI) prog...

Thymic health and immunotherapy outcomes in patients with cancer.

Although immunotherapy has revolutionized cancer treatment, many patients still experience limited b...

The interplay between Peptostreptococcus and Fusobacterium as novel signatures in colorectal cancer recurrence.

BACKGROUND: After resection surgery, recurrence occurs in more than 30% of colorectal cancer (CRC) p...

Veteran oropharyngeal cancer outcomes in the modern era: a multi-institutional retrospective analysis.

OBJECTIVE: To define oncologic outcomes in Veterans in the modern era using a multi-institutional co...

AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma.

IMPORTANCE: Cancer antigen 19-9 (CA19-9) is used to assess treatment response among patients with pa...

A Scoping Review of Machine Learning Applications for Diagnosis, Classification, and Prognosis in Lupus Nephritis.

BACKGROUND: Over the past decade, machine learning (ML) has transformed histopathology, yet its appl...

Letter: Beyond One-Size-Fits-All: Rethinking Early Palliative Cancer Care Through Personalization and Artificial Intelligence.

Artificial Intelligence for Predicting Treatment Response in Patients With Anxiety Disorders After Cognitive Behavioral Therapy: Systematic Review and Meta-Analysis.

BACKGROUND: Artificial intelligence (AI) models have been increasingly explored for predicting treat...

Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio.

BACKGROUND: The tumour-stroma ratio (TSR) is a potential prognostic indicator, yet hindered by quant...

dMMR prediction from colorectal cancer histopathology: Leveraging non-tumor and low-magnification regions.

BACKGROUND AND OBJECTIVE: Colorectal cancer is the second leading cause of cancer-related mortality ...

LymphUs: A multicenter open-access database of lymph node ultrasound images in patients with papillary thyroid carcinoma for clinical and artificial intelligence research.

Approximately 30-50% of Papillary thyroid carcinoma (PTC) patients develop cervical lymph nodes (LNs...

A generative explainable model for antimicrobial peptide prediction using bidirectional temporal convolutional neural network.

Advances in artificial intelligence (AI) and multi-omics integration are reshaping precision oncolog...

Signs and symptoms indicating the transition to the palliative phase in patients with COPD and heart failure in primary healthcare: a mixed-methods study.

The pre-metastatic niche: mechanisms, heterogeneity, and therapeutic opportunities.

Metastasis remains the leading cause of cancer-related mortality. The concept of the pre-metastatic ...

Unraveling the diagnostic and prognostic signatures of oral microbiota in head and neck cancer.

BACKGROUND: Head and neck cancer, predominantly squamous cell carcinoma, has emerged as a significan...

Decoding the immune-tumor synapse for data-driven design of next-generation immunotherapies.

The immunological synapse (IS) formed between cytotoxic CD8+ T lymphocytes (CTLs) and tumor cells re...

Tumor organoids on-a-chip and the role of AI in predictive oncology and personalized cancer medicine.

The drug development process in cancer faces significant challenges due to high failure rates in tra...

Immune checkpoint molecules beyond PD-1 and CTLA-4: emerging targets in autoimmune diseases and cancer immunotherapy.

BACKGROUND: Immune checkpoint molecules are pivotal regulators of immune activation and tolerance, p...